Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study

M. Zemanová, B. Staňková, Z. Ušiakova, E. Tvrzická, A. Pazdro, L. Petruželka, M. Zeman,

. 2014 ; 20 (-) : 2351-2357.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT12331 MZ0 CEP Register

BACKGROUND: The convergence of nutritional, genetic, and inflammatory factors plays a significant role in the pathophysiology of squamous cell esophageal cancer (SCEC). The parameters of inflammation, indices of nutritional status, and adipocyte-derived hormones such as leptin, adiponectin, and resistin have been shown to be prognostic factors in some gastrointestinal and pancreatic cancers. MATERIAL/METHODS: Forty-two patients with SCEC were subjected to a multimodal regimen of concurrent neoadjuvant chemoradiotherapy (CRT) followed by surgery. We retrospectively analyzed the impact of pretreatment values of serum leptin, adiponectin, resistin, soluble leptin receptor, C-reactive protein, TNF alpha, leukocytes, and indices of nutritional status (BMI, plasma total protein, albumin, cholesterol, and triacylglycerols) on overall survival (OS). RESULTS: Univariate analysis revealed significant a negative correlation between OS and serum adiponectin (p=0.027), and a positive relationship was found between serum albumin (p=0.002), cholesterol (p=0.049) level, and OS. In multivariate analysis, only the trend (p=0.086) for negative serum adiponectin association with the OS was observed. CONCLUSIONS: In men with SCEC treated by neoadjuvant concurrent CRT and esophagectomy, high pretreatment level of serum adiponectin was associated with shorter OS while the serum albumin and cholesterol were associated with longer OS.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15022928
003      
CZ-PrNML
005      
20181213110443.0
007      
ta
008      
150709s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.12659/MSM.891088 $2 doi
035    __
$a (PubMed)25408239
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zemanová, Milada $u Clinic of Oncology, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0060597
245    10
$a Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study / $c M. Zemanová, B. Staňková, Z. Ušiakova, E. Tvrzická, A. Pazdro, L. Petruželka, M. Zeman,
520    9_
$a BACKGROUND: The convergence of nutritional, genetic, and inflammatory factors plays a significant role in the pathophysiology of squamous cell esophageal cancer (SCEC). The parameters of inflammation, indices of nutritional status, and adipocyte-derived hormones such as leptin, adiponectin, and resistin have been shown to be prognostic factors in some gastrointestinal and pancreatic cancers. MATERIAL/METHODS: Forty-two patients with SCEC were subjected to a multimodal regimen of concurrent neoadjuvant chemoradiotherapy (CRT) followed by surgery. We retrospectively analyzed the impact of pretreatment values of serum leptin, adiponectin, resistin, soluble leptin receptor, C-reactive protein, TNF alpha, leukocytes, and indices of nutritional status (BMI, plasma total protein, albumin, cholesterol, and triacylglycerols) on overall survival (OS). RESULTS: Univariate analysis revealed significant a negative correlation between OS and serum adiponectin (p=0.027), and a positive relationship was found between serum albumin (p=0.002), cholesterol (p=0.049) level, and OS. In multivariate analysis, only the trend (p=0.086) for negative serum adiponectin association with the OS was observed. CONCLUSIONS: In men with SCEC treated by neoadjuvant concurrent CRT and esophagectomy, high pretreatment level of serum adiponectin was associated with shorter OS while the serum albumin and cholesterol were associated with longer OS.
650    _2
$a adiponektin $x krev $7 D052242
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a spinocelulární karcinom $x krev $x chirurgie $x terapie $7 D002294
650    12
$a chemoradioterapie $7 D059248
650    _2
$a nádory jícnu $x krev $x chirurgie $x terapie $7 D004938
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a pilotní projekty $7 D010865
650    12
$a předoperační péče $7 D011300
650    _2
$a proporcionální rizikové modely $7 D016016
650    _2
$a analýza přežití $7 D016019
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Staňková, Barbora $u 4th Department of Internal Medicine, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0133413
700    1_
$a Bielčíková, Zuzana $u Clinic of Oncology, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0225233
700    1_
$a Tvrzická, Eva $u 4th Department of Internal Medicine, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0076496
700    1_
$a Pazdro, Alexandr $u 3rd Clinic of Surgery, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0093307
700    1_
$a Petruželka, Luboš, $u Clinic of Oncology, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $d 1952- $7 jn19990209650
700    1_
$a Zeman, Miroslav, $u 4rd Department of Internal Medicine, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $d 1950- $7 skuk0006053
773    0_
$w MED00003251 $t Medical science monitor international medical journal of experimental and clinical research $x 1643-3750 $g Roč. 20, č. - (2014), s. 2351-2357
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25408239 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20181213110608 $b ABA008
999    __
$a ok $b bmc $g 1083267 $s 905921
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 20 $c - $d 2351-2357 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
GRA    __
$a NT12331 $p MZ0
LZP    __
$a Pubmed-20150709

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...